12 Campus Blvd, Newtown Square, PA 19073, USA
(610) 325-9814
(610) 325-9823

 PPXRD-13 Presentations

May 2015 – Bad Herrenalb, Germany

PPXRD-13 Workshop presentations

Presentation Title Authors
‣ Quantification of Amorphous Phases – Theory Robert Dinnebier, Max-Planck Institute für Festkoerperforschung, Stuttgart, Germany
‣ Quantitative Phase Analysis with Diffraction Methods Fabia Gozzo, Excelsus Structural Solutions SPRL, Brussels, Belgium
‣ QPA instrumentation, sample and validation aspects Detlef Beckers, PANalytical B.V., The Netherlands
‣ Quantification of traces – pushing the limits with laboratory instrumentation Detlef Beckers, PANalytical B.V., The Netherlands
‣ Quantitative phase analysis by XRPD Arnt Kern, Burker AXS GmbH, Germany
Detlef Beckers, PANalytical B.V., The Netherlands
Fabia Gozzo, Excelsus Structural Solutions SPRL, Belgium
Robert Dinnebier, MPI für Festkörperforschung, Germany
Arnaud Grandeury, Novartis Pharma AG

PPXRD-13 Session presentations

Presentation Title Authors
‣ The Relationship Between Stability and X-ray Powder Diffraction Profile for Non-crystalline Solid Forms Simon Bates, D. Jonaitis, T. Capozzi, P. Stahly, Triclinic Labs, Lafayette, IN, U.S.A.
‣ Study of Biological Macromolecules with a Labortory X-ray Diffraction System Detlef Beckers, T. Degen, G. Nénert, J. Bolze, PANalytical B.V., Almelo, The Netherlands
S. Saslis, S. Logotheti, I. Margiolaki, University of Patras, Patras, Greece
V. Kogan, Dannalab, Enschede, The Netherlands
‣ Structural Characterization and Rationalization of Formation, Stability, and Transformations of Benperidol Solvates Agris Bērziņš, University of Latvia, Riga, Latvia and Durham University, Durham, UK
E. Skarbulis, A. Actinš, University of Latvia, Riga, Latvia
‣ ICDD Powder Diffraction File® Coverage of Polymers Used in Pharmaceutical and Biomedical Applications Tom Blanton, S. Gates, ICDD, Newtown Square, PA, U.S.A.
‣ Ultrafast Crystal Structure Determination of Pharmaceutical Compounds using TEM Electron Diffraction without Cooling Techniques Partha Pratim Das, NanoMEGAS SPRL, Brussels, Belgium & Electron Crystallography Solutions, Madrid, Spain
E. Van Genderen, J.P. Abrahams, University of Leiden, Leiden, Netherlands
S. Nicolopoulos, NanoMEGAS SPRL, Brussels, Belgium
‣ Molecular Complexes of Agomelatine-Phosphoric Acid: Crystal Structure Determination and Phase Transformation Kinetics by Non-Ambient Powder XRD R.S. Voguri, R.R. Chirla, Archan Dey, Dr. Reddy’s Laboratories Limited, Hyderabad, India
‣ Analyzing Amorphous and Nanocrystalline Materials by Full Pattern Analyses Timothy Fawcett, S.N. Kabekkodu, K. Zhong, A.M. Gindhart, J.R. Blanton, T.N. Blanton, ICDD, Newtown Square, PA, U.S.A.
‣ Optimizing PDF Data Quality using a Laboratory Powder Diffractometer Thomas Hartmann, Stoe & Cie GmbH, Darmstadt, Germany
‣ Expanding the Scope of PDF4/Organics in Pharmaceutical PXRD Analysis S.N. Kabekkodu, T.G. Fawcett, K. Zhong, A.M. Gindhart, S. Gates, J.R. Blanton, T.N. Blanton, ICDD, Newtown Square, PA, U.S.A.
‣ Crystal Structures of Large-Volume Commercial Pharmaceuticals with Z’>1 James Kaduk, Illinois Institute of Technology, Chicago, IL, U.S.A.
J.W. Reid, Canadian Light Source, Saskatoon, Canada
R. Papoular, Leon Brillouin Lab., Saclay, France
K. Zhong, A.M. Gindhart, T.N. Blanton, ICDD, Newtown Square PA, U.S.A.
‣ The Power of Powder: Protein-based Drug Screening Irene Margiolaki, University of Patras, Patras, Greece
‣ Instrumentation for Tackling Current and Future Challenges in Pharmaceutical R&D Dubravka Šišak Jung, DECTRIS Ltd, Baden, Switzerland
T. Hartmann, Stoe & Cie GmbH, Darmstadt, Germany
‣ Verification of Crystal Structures Determined from PXRD— the Role of DFT-D Jacco van de Streek, University of Copenhagen, Copenhagen, Denmark